Literature DB >> 702047

Leukocyte surface origin of human alpha1-acid glycoprotein (orosomucoid).

C G Gahmberg, L C Andersson.   

Abstract

Specific antibodies against human alpha1-acid glycoprotein reacted with human lymphocytes, granulocytes, and monocytes. The antigen on the leukocytes is an externally located integral membrane glycoprotein which is made by the cells and has an apparent mol wt of 52,000. It is released from cells in vitro to the culture medium. The mol wt of the soluble fragment is 41,000, which corresponds to that of alpha1-acid glycoprotein in serum and urine. Peptide mapping confirmed that the main part of the cellular membrane antigen consists of alpha1-acid glycoprotein with an additional, probably hydrophobic fragment. This finding may partially explain the increase in the serum levels of alpha1-acid glycoprotein observed in many disorders involving leukocyte proliferation. In addition, the known sequence homology of alpha1-acid glycoprotein with immunoglobulins can now be more easily understood by their origin in similar cell types.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702047      PMCID: PMC2184935          DOI: 10.1084/jem.148.2.507

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Sunthesis of alphal-acid glycoprotein by the isolated perfused rat liver.

Authors:  E J SARCIONE
Journal:  Arch Biochem Biophys       Date:  1963-03       Impact factor: 4.013

4.  Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

Authors:  K M Chiu; R F Mortensen; A P Osmand; H Gewurz
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Studies on the mucoproteins of human plasma. V. Isolation and characterization of a homogeneous mucoprotein.

Authors:  H E WEIMER; J W MEHL; R J WINZLER
Journal:  J Biol Chem       Date:  1950-08       Impact factor: 5.157

7.  Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines.

Authors:  K Nilsson; L C Andersson; C G Gahmberg; H Wigzell
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

8.  Cortisone as a probe for cell interactions in the generation of cytotoxic T cells. I. Effect on helper cells, cytotoxic T cell precursors, and accessory cells.

Authors:  K C Lee
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

9.  Detergent solubilization, purification, and separation of specificities of HLA antigens from a cultured human lymphoblastoid line, RPMI 4265.

Authors:  T A Springer; D L Mann; A L DeFranco; J L Strominger
Journal:  J Biol Chem       Date:  1977-07-10       Impact factor: 5.157

10.  Characterization of surface glycoproteins of mouse lymphoid cells.

Authors:  C G Gahmberg; P Häyry; L C Andersson
Journal:  J Cell Biol       Date:  1976-03       Impact factor: 10.539

View more
  34 in total

Review 1.  Inflammatory and autoimmune diseases of the nervous system; possibilities of laboratory diagnostic methods in cerebrospinal fluid.

Authors:  Z Lodin
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.

Authors:  B E Turk; H Jiang; J O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  Differentiation of human erythroid cells is associated with increased O-glycosylation of the major sialoglycoprotein, glycophorin A.

Authors:  C G Gahmberg; M Ekblom; L C Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Surface glycoproteins of resting and activated human T lymphocytes.

Authors:  L C Andersson; C G Gahmberg
Journal:  Mol Cell Biochem       Date:  1979-10-15       Impact factor: 3.396

5.  Differences between the carbohydrate units of cell-surface glycoproteins of moust B- and T-lymphocytes.

Authors:  T Krusius; J Finne; L C Andersson; C G Gahmberg
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

6.  Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis.

Authors:  T Hochepied; A Wullaert; F G Berger; H Baumann; P Brouckaert; L Steidler; C Libert
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development.

Authors:  M Yiangou; C Konidaris; P Victoratos; L Hadjipetrou-Kourounakis
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Specific changes in the surface glycoprotein pattern of human promyelocytic leukemic cell line HL-60 during morphologic and functional differentiation.

Authors:  C G Gahmberg; K Nilsson; L C Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression.

Authors:  D A Cheresh; D H Haynes; J A Distasio
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

10.  The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.

Authors:  Fei Li; Zhe Yu; Pengliang Chen; Guangzheng Lin; Tieqiu Li; Lina Hou; Yuejun Du; Wanlong Tan
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.